Kengrexal
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kengrexal, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: EMA Authorised: Kengrexal (cangrelor) — Chiesi Farmaceutici S.p.A.